Innogenetics NV - Strategic SWOT Analysis Review

Summary

Innogenetics NV (Innogenetics) is a biotechnological company engaged in developing and marketing of a wide range of diagnostic assays with emphasis on molecular diagnostics. The company has two divisions, namely, diagnostics and biological. Its diagnostics business is engaged in the development of value-added products for infectious diseases, genetic testing, transplantation, neurodegeneration, oncology and others. Biologicals division comprises of a process development unit and a manufacturing unit which help in production and optimization of fermentation, purification process and formulation along with method development for in-process controls and quality controls of final drug substance and products. The company has 6 subsidiaries. Immunogenetics is headquartered in Gent, Belgium and operates as a subsidiary of Fujirebio Inc., a subsidiary of Miraca Holdings Inc.

GlobalData’s Innogenetics NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Note: Some sections may be missing if data is unavailable for the company.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

List of Tables 3
List of Figures 3
Section 1 - About the Company 4
Innogenetics NV - Key Facts 4
Innogenetics NV - Key Employees 5
Innogenetics NV - Key Employee Biographies 6
Innogenetics NV - Major Products and Services 7
Innogenetics NV - History 9
Innogenetics NV - Locations And Subsidiaries 11
Head Office 11
Other Locations & Subsidiaries 11
Section 2 – Company Analysis 12
Innogenetics NV - Business Description 12
Innogenetics NV - Corporate Strategy 13
Innogenetics NV - SWOT Analysis 14
SWOT Analysis - Overview 14
Innogenetics NV - Strengths 14
Strength - Presence in Geographically Diverse Markets 14
Strength - Diversified product portfolio 14
Strength - Strategic Partnerships and Alliances 14
Innogenetics NV - Weaknesses 14
Weakness - Weak sales and distribution capabilities 14
Weakness - Private Ownership 14
Innogenetics NV - Opportunities 15
Opportunity - Growing Aged Population 15
Opportunity - Growth in Emerging Economies 15
Opportunity - Product Innovation and Development 15
Innogenetics NV - Threats 15
Threat - Use of hazardous materials 15
Threat - Stringent regulation 15
Threat - Technological Changes 16
Threat - Highly Competitive Environment 16
Innogenetics NV - Key Competitors 17
Section 3 – Company’s Lifesciences Financial Deals and Alliances 18
Innogenetics NV, Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012 18
Innogenetics NV, Pharmaceuticals & Healthcare, Deals By Type, 2006 to YTD 2012 19
Innogenetics NV, Medical Equipment, Deals By Year, 2006 to YTD 2012 20
Innogenetics NV, Medical Equipment, Deals By Type, 2006 to YTD 2012 21
Innogenetics NV, Recent Deals Summary 22
Section 4 – Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables

Innogenetics NV, Key Facts 4
Innogenetics NV, Key Employees 5
Innogenetics NV, Key Employee Biographies 6
Innogenetics NV, Major Products and Services 7
Innogenetics NV, History 9
Innogenetics NV, Subsidiaries 11
Innogenetics NV, Key Competitors 17
Innogenetics NV, Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012 18
Innogenetics NV, Pharmaceuticals & Healthcare, Deals By Type, 2006 to YTD 2012 19
Innogenetics NV, Medical Equipment, Deals By Year, 2006 to YTD 2012 20
Innogenetics NV, Medical Equipment, Deals By Type, 2006 to YTD 2012 21
Innogenetics NV, Recent Deals Summary 22

List of Figures

Innogenetics NV, Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012 18
Innogenetics NV, Pharmaceuticals & Healthcare, Deals by Type, 2006 to YTD 2012 19
Innogenetics NV, Medical Equipment, Deals By Year, 2006 to YTD 2012 20
Innogenetics NV, Medical Equipment, Deals by Type, 2006 to YTD 2012 21